Therapeutic Metabolic Reprograming Using microRNAs: From Cancer to HIV Infection

Area of Science:

• Biochemistry
• Immunology
• Oncology

Background:

• MicroRNAs (miRNAs) are key regulators of cellular metabolism and play roles in cancer progression.
• Cancer cells exhibit significant metabolic alterations, and immunometabolism research reveals unique metabolic signatures in immune cells.
• CD4+ T-cell susceptibility to HIV infection is linked to their metabolic activity, sharing similarities with cancer cell metabolism.

Purpose of the Study:

• To review the potential of miRNA modulation for metabolic reprogramming in cancer therapy.
• To explore the application of miRNA-based metabolic reprogramming for restricting HIV replication and eliminating infected cells.

Main Methods:

• Literature review of studies on miRNA function in cellular metabolism, cancer, and HIV infection.
• Analysis of the link between metabolic changes in cancer and HIV-infected cells.
• Discussion of therapeutic strategies involving miRNA modulation.

Main Results:

• miRNA-mediated metabolic reprogramming is a viable strategy for cancer treatment.
• Metabolic similarities between cancer and HIV-infected cells suggest a shared therapeutic vulnerability.
• Targeting cellular metabolism via miRNAs could offer a novel approach to combat HIV.

Conclusions:

• miRNA-based metabolic reprogramming holds significant therapeutic potential for both cancer and HIV.
• Further research into immunometabolism and miRNA regulation is crucial for developing these novel therapies.